Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

PLGA nanoparticles containing raltegravir and efavirenz

Based on

1 Patents
2014 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

poly(lactic-co-glycolic acid)

PLGA
Type Polymer
Formula
Role carriers
2

raltegravir

Type Single Compound
Formula C20H21FN6O5
Role loaded material
3

efavirenz

EFV
Type Single Compound
Formula C14H9ClF3NO2
Role loaded material

Properties

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
scanning electron microscopy

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
H9 cells

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • poly(lactic-co-glycolic acid)
  1. pgxZOqNaO7ep5
  2. eEGCIql21Zhs0
  3. ekBf
Product

PLGA nanoparticles containing raltegravir and efavirenz

Size: 75.4 - 88.2 nm

Medium: citrate buffer

Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial